Immunotherapy in Malignant Pleural Mesothelioma
New data confirm combination nivolumab and ipilimumab as the best treatment for unresectable malignant pleural mesothelioma.
New data confirm combination nivolumab and ipilimumab as the best treatment for unresectable malignant pleural mesothelioma.